
Opinion|Videos|July 16, 2024
Differentiating Between the Semi-Fluorinated Alkane-Based Therapies for Dry Eye
Selina McGee, OD, FAAO, discusses the role of cyclosporine ophthalmic solution (VEVYE) in the treatment of dry eye disease.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- When do you prefer to use cyclosporine ophthalmic solution, 0.1% (VEVYE)? How are the indications for this drug different from perfluorohexyloctane ophthalmic solution?
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
South Korea's MFDS receives NDA for Tenpoint Therapeutics' Brimochol PF for presbyopia
2
Interventional glaucoma: Redefining the optometrist’s role in modern glaucoma management
3
Fitting the future: How technology is refining specialty lens care
4


















































.png)


